1. Home
  2. SOS vs BRTX Comparison

SOS vs BRTX Comparison

Compare SOS & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOS Limited

SOS

SOS Limited

N/A

Current Price

$1.56

Market Cap

10.7M

Sector

Finance

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.16

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOS
BRTX
Founded
2004
1997
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Managed Health Care
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
9.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SOS
BRTX
Price
$1.56
$1.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
69.3K
35.9K
Earning Date
09-26-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$260,505,000.00
$383,400.00
Revenue This Year
N/A
$112.14
Revenue Next Year
N/A
$139.81
P/E Ratio
N/A
N/A
Revenue Growth
134.43
1.70
52 Week Low
$1.02
$0.98
52 Week High
$9.62
$2.55

Technical Indicators

Market Signals
Indicator
SOS
BRTX
Relative Strength Index (RSI) 52.27 49.45
Support Level $1.51 $1.00
Resistance Level $1.63 $1.21
Average True Range (ATR) 0.18 0.09
MACD 0.02 0.02
Stochastic Oscillator 34.59 69.57

Price Performance

Historical Comparison
SOS
BRTX

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: